Impact of PERIOD. and Advisory Board's Efforts
PERIOD., a global advocacy organization dedicated to eradicating period poverty, is thrilled to celebrate the successful inaugural year of its Advisory Board. This groundbreaking initiative is primarily focused on addressing the pervasive issue of period poverty and stigma that many individuals encounter, especially in the workplace.
Corporate Partnerships and Support
Noteworthy member corporations such as Pfizer, Sumitomo Pharma, Motrin, and Thinx have lent their expertise and resources to support PERIOD.'s goals. Their commitment has been crucial in advancing advocacy and educational initiatives aimed at equipping workplaces to better address menstruation and its associated challenges.
Providing Expert Guidance
These corporate partners have contributed significantly to discussions around menstruation in the workplace, enhancing employee support systems. By sharing their knowledge and resources, they help ensure individuals feel comfortable discussing and managing menstrual health at their places of employment.
Highlighting Conversations in a New Video
As part of the celebration, the Advisory Board hosted a roundtable video discussion where leaders from various sectors engaged in candid conversations about menstrual health in the workplace. This vital discussion explored various topics, including how companies can create environments that acknowledge and support menstruation, menstrual discomfort, and menopause.
Understanding the Stigma
A recent study sheds light on the stark realities of period stigma: 60% of adults reported that such stigma directly affects their comfort with their own bodies. Additionally, 46% expressed concern that requesting accommodations at work for menstrual health could hinder their career advancement. This stigma is especially pronounced among lower-income populations, where the challenges of affording menstrual products are even greater.
Advocacy for Change
Michela Bedard, Executive Director of PERIOD., emphasized that the ambitious work of the Advisory Board will inspire further action from employers and policymakers. By advocating for improved menstrual product accessibility, they aim to create a supportive culture that encourages dialogue and removes barriers tied to period poverty.
Pioneering New Initiatives
The ongoing efforts align with PERIOD.'s Workplace Champions program, which actively engages large employers in creating a supportive work environment. This includes ensuring access to menstrual products and educational resources about menstruation, which empowers employees to handle their menstrual health with dignity.
About PERIOD.
Founded as a youth-led nonprofit, PERIOD. operates globally to end period poverty through education, advocacy, and direct service. With numerous chapters worldwide, they focus on distributing menstrual supplies, developing comprehensive menstrual health curricula, and promoting youth leadership. Their initiatives champion laws to make menstruation products more affordable and accessible.
To learn more about PERIOD.'s integral work in combating period poverty, visit their website and join the movement on social media.
Frequently Asked Questions
What is the mission of PERIOD.?
PERIOD. aims to combat period poverty and stigma through advocacy, education, and direct service.
Who is part of the Advisory Board?
The Advisory Board includes members from companies like Pfizer, Sumitomo Pharma, Motrin, and Thinx, all dedicated to ending period poverty.
How does PERIOD. address workplace issues related to menstruation?
PERIOD. encourages workplaces to create inclusive environments by providing period products and educational resources.
What are the key findings from the State of the Period study?
The study highlights that 60% of adults feel period stigma affects their body comfort, and many fear career impacts from requesting accommodations.
In what ways can individuals support PERIOD.'s mission?
Individuals can support PERIOD. by using their platform, volunteering, and spreading awareness about period poverty and its implications.
